What is Integrated Biopharma?
Integrated Biopharma operates as a critical node in the global supply chain for fine chemicals, science-based proprietary products, and value-added formulations. By bridging the gap between raw material sourcing and end-market application, the company serves a diverse clientele across the nutritional, pharmaceutical, food, and cosmetic sectors. Its extensive product portfolio—ranging from essential vitamins and amino acids to specialized herbal extracts and excipients—positions the firm as a versatile partner for manufacturers requiring high-purity ingredients. Through its commitment to quality and distribution efficiency, Integrated Biopharma maintains a robust competitive advantage in the life sciences and wellness supply chain.
How much funding has Integrated Biopharma raised?
Integrated Biopharma has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Integrated Biopharma
PPP
Public-Private Partnership
What's next for Integrated Biopharma?
With the infusion of this recent capital, Integrated Biopharma is well-positioned to accelerate its strategic initiatives, focusing on supply chain optimization and the expansion of its proprietary product catalog. The company is expected to leverage these resources to enhance its distribution infrastructure, potentially exploring new market segments within the OTC pharmaceutical space. As the firm transitions into this next phase of growth, the focus will likely remain on scaling operational capacity to meet the rising global demand for high-quality nutritional and chemical formulations, ensuring sustained value creation for its stakeholders.
See full Integrated Biopharma company page
